Chang CF, Lai JH, Wu JC, Greig NH, Becker RE, Luo Y, Chen YH, Kang SJ, Chiang YH, Chen KY (2017)
(-)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury
Brain Research 1677: 118

Tweedie D, Fukui K, Li Y, Yu QS, Barak S, Tamargo IA, Rubovitch V, Holloway HW, Lehrmann E, Wood WH, 3rd, Zhang Y, Becker KG, Perez E, Van Praag H, Luo Y, Hoffer BJ, Becker RE, Pick CG, Greig NH (2016)
Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms
PLoS ONE 11: e0156493

Giacobini E, Becker RE (2007)
One hundred years after the discovery of Alzheimer's disease. A turning point for therapy?
J Alzheimers Dis 12: 37

Becker RE (2006)
Treating Alzheimer's disease: do clinical trial methods produce unnecessary practitioner dilemmas?
Am J Alzheimers Dis Other Demen 21: 81

Moriearty PL, Seubert P, Galasko D, Markwell S, Unni L, Vicari S, Becker RE (1999)
Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease
Methods Find Exp Clin Pharmacol 21: 549

Becker RE, Colliver JA, Markwell SJ, Moriearty PL, Unni LK, Vicari S (1998)
Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study
lzheimer Disease & Associated Disorders 12: 54

Kronforst-Collins MA, Moriearty PL, Ralph M, Becker RE, Schmidt B, Thompson LT, Disterhoft JF (1997)
Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits
Pharmacology, Biochemistry & Behavior 56: 103

Bartels CF, Moriearty PL, Becker RE, Mountjoy CP, Lockridge O (1995)
Acetylcholinesterase Gene Sequence and Copy Number are Normal in Alzheimer's Disease Patients Treated with the Organophosphate Metrifonate
In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp.: 479

Unni LK, Womack C, Hannant ME, Becker RE (1994)
Pharmacokinetics and pharmacodynamics of metrifonate in humans
Methods Find Exp Clin Pharmacol 16: 285

Unni LK, Radcliffe J, Latham G, Sunderland T, Martinez R, Potter W, Becker RE (1994)
Oral administration of heptylphysostigmine in healthy volunteers: a preliminary study
Methods Find Exp Clin Pharmacol 16: 373

Moriearty PL, Thornton SL, Becker RE (1993)
Transdermal patch delivery of acetylcholinesterase inhibitors
Methods Find Exp Clin Pharmacol 15: 407

Moriearty PL, Becker RE (1992)
Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL)
Methods Find Exp Clin Pharmacol 14: 615

Unni LK, Hutt V, Imbimbo BP, Becker RE (1991)
Kinetics of cholinesterase inhibition by eptastigmine in man [letter]
European Journal of Clinical Pharmacology 41: 83

Kumar V, Becker RE (1989)
Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease
Int J Clinical Pharmacology & Therapeutics Toxicol 27: 478